Mydecine Innovations Group is an American and Canadian biotechnology company developing innovative first- and second-generation novel therapeutics for mental health and addiction treatment. The company focuses on psychedelic-derived medicines and entactogens, leveraging world-class technology and controlled drug delivery systems. Mydecine achieved the first legal import of magic mushrooms into Canada in 2021 and maintains a robust R&D pipeline despite financial challenges in 2022. Signal Plug searches live against mydecine.com's mail server to find and verify email addresses for any Mydecine Innovations Group employee.
Signal Plug searches live against mydecine.com's mail server — not a static database. Get a verified email for any Mydecine Innovations Group employee with confidence score in under 2 seconds.
94% accuracy · No credit card required · 10 free searches/month
Mydecine Innovations Group is an American and Canadian biotechnology company developing innovative first- and second-generation novel therapeutics for mental health and addiction treatment. The company focuses on psychedelic-derived medicines and entactogens, leveraging world-class technology and controlled drug delivery systems. Mydecine achieved the first legal import of magic mushrooms into Canada in 2021 and maintains a robust R&D pipeline despite financial challenges in 2022.
Competitive Advantage
Mydecine conducted the first legal import of magic mushrooms into Canada in 2021, pioneering regulatory acceptance of psilocybin materials. The company has patented novel short-acting MDMA analogues (MY100 and MY101) designed for improved safety profiles. Despite August 2022 financial distress threatening shutdown, Mydecine secured emergency funding and continued operations, demonstrating investor confidence in psychedelic therapeutics. The pipeline includes a patch-delivery system (MYCO-004) for improved patient compliance with psychedelic medicines.
The most commonly verified format at Mydecine Innovations Group:
Medium ConfidenceSignal Plug tests all common patterns against Mydecine Innovations Group's live mail server and returns whichever passes the SMTP check.
Run a live search for Mydecine Innovations Group →Data-driven signals to help you prospect Mydecine Innovations Group effectively.
Clinical research organizations, mental health treatment providers, addiction treatment centers, and institutional investors interested in emerging psychedelic therapeutics would be primary buyers. Recruitment targets scientific researchers, chemists, clinical trial managers, and regulatory affairs specialists experienced in novel drug development.
Primary Contact
Chief Medical Officer
Tuesday–Thursday, 9am–11am
Signal Plug performs live SMTP verification against mydecine.com's mail server — not a static scraped database — which means results reflect the real, current state of Mydecine Innovations Group's email infrastructure. Here's how to run a lookup:
Create a free account
Sign up at Signal Plug in under 30 seconds. No credit card required. The Free plan includes 10 searches per month so you can test the tool with real Mydecine Innovations Group contacts before upgrading.
Enter the contact's name
Type the first and last name of the Mydecine Innovations Group employee you want to reach. Signal Plug handles all seniority levels, from C-suite to individual contributors.
Enter the domain
Use mydecine.com. Signal Plug tests all common naming patterns automatically and returns only the format that passes the SMTP check.
Get a verified result
Signal Plug returns an email address with a confidence score (0–100) and deliverability status (Valid, Risky, or Catch-all) within 2 seconds. The confidence score tells you how reliable the result is before you use it.
Export and use
One-click CSV export lets you bring Mydecine Innovations Group contacts into Salesforce, HubSpot, Outreach, Lemlist, or any other tool in your stack. Growth and Scale plan users can run bulk lookups across an entire list of Mydecine Innovations Group names in a single batch.
Whether you're running outbound sales, recruiting, or building a partnership list, these are the roles most frequently contacted at Biotechnology like Mydecine Innovations Group.
Based on Mydecine Innovations Group's profile, the highest-value contacts for outbound are:
Signal Plug works for any role at any seniority level at mydecine.com. If you have a name and the domain, you can find a verified email.
How well Mydecine Innovations Group fits a typical B2B outbound pipeline, based on available signals.
Good Fit
Funnel Fit Score
Most email finder tools pull from static databases of scraped email addresses. These databases go stale as people change jobs and companies update their email infrastructure. Signal Plug takes a different approach: every search performs a live check against mydecine.com's mail server using SMTP verification. This means results reflect the current state of Mydecine Innovations Group's email system — not a cached result from months or years ago.
Signal Plug enriches every result with supporting data: a confidence score (0–100), deliverability status (Valid, Risky, or Catch-all), job title where available, and LinkedIn profile URL. This context helps you prioritize which Mydecine Innovations Group contacts to email first and personalize your outreach before you hit send. Plans start at $29/month for 500 searches — no annual contracts or seat fees.
Signal Plug performs a live SMTP check against mydecine.com's mail server for every query — not a static database lookup. Our platform-wide accuracy rate is 94%. Each result comes with a confidence score (0–100) so you can gauge reliability before using the address.
Free plan: 10 searches. Starter ($29/mo): 500. Growth ($149/mo): 2,000. Scale ($299/mo): 5,000. No company-specific caps.
No. Signal Plug generates and verifies emails in real time via SMTP checks — no static database of Mydecine Innovations Group employee emails is maintained.
Yes. Growth and Scale plan users can upload a CSV of names and run bulk lookups against mydecine.com in a single batch.
Mydecine develops psychedelic-derived therapeutics and novel entactogens for mental health and addiction treatment.
Mydecine is an American and Canadian company.
Key candidates include MYCO-001 and MYCO-003 (psilocybin), MYCO-002 (safer MDMA-like compound), MYCO-004 (patch-delivered tryptamine), MYCO-005 (novel aza psilocin), and short-acting variants MYCO-006 and MYCO-007.
Yes, in 2021 Mydecine completed the first legal import of magic mushrooms into Canada.
Signal Plug searches in real time against mydecine.com's mail server to find and verify email addresses for Mydecine Innovations Group employees. Enter a name, enter the domain, get a verified result with a confidence score in under 2 seconds.
Start finding emails free →10 free searches · No credit card required · Upgrade from $29/month